Novel Strategy May Help Suppress Resistance to Current Cancer Therapies - Genetic Engineering & Biotechnology News

Researchers have identified a strategy to break down tumor cell-surface PD-L1 to make tumors more susceptible to immune attack.

PD-L1  is a protein that acts as a kind of brake to keep immune responses under control.  One way cancer cells defend against tumor-killing immune cells is to load up their cell surface with PD-L1. N… [+3450 chars]

full article...